Cryotherapy for the prevention of high-dose melphalan-induced oral mucositis
- PMID: 16953203
- DOI: 10.1038/sj.bmt.1705494
Cryotherapy for the prevention of high-dose melphalan-induced oral mucositis
Comment on
-
A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.Bone Marrow Transplant. 2006 Jun;37(11):1031-5. doi: 10.1038/sj.bmt.1705384. Bone Marrow Transplant. 2006. PMID: 16633359 Clinical Trial.
Similar articles
-
A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.Bone Marrow Transplant. 2006 Jun;37(11):1031-5. doi: 10.1038/sj.bmt.1705384. Bone Marrow Transplant. 2006. PMID: 16633359 Clinical Trial.
-
[Cryotherapy is useful and safe in the prevention of oral mucositis after high-dose melphalan (L-PAM)].Rinsho Ketsueki. 2006 Nov;47(11):1469-71. Rinsho Ketsueki. 2006. PMID: 17176891 Japanese.
-
Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma.J Support Oncol. 2007 May;5(5):231-5. J Support Oncol. 2007. PMID: 17564153
-
New developments in conditioning regimens before auto-SCT in multiple myeloma.Bone Marrow Transplant. 2011 Jul;46(7):911-5. doi: 10.1038/bmt.2011.20. Epub 2011 Feb 28. Bone Marrow Transplant. 2011. PMID: 21358678 Review.
-
The role of transplant in multiple myeloma.Clin Adv Hematol Oncol. 2005 Aug;3(8):604-6. Clin Adv Hematol Oncol. 2005. PMID: 16167043 Review. No abstract available.
Cited by
-
Systematic review of oral cryotherapy for the management of oral mucositis in cancer patients and clinical practice guidelines.Support Care Cancer. 2020 May;28(5):2449-2456. doi: 10.1007/s00520-019-05217-x. Epub 2019 Dec 14. Support Care Cancer. 2020. PMID: 31836937
-
Oral cryotherapy for oral mucositis management in patients receiving allogeneic hematopoietic stem cell transplantation: a prospective randomized study.Support Care Cancer. 2020 Apr;28(4):1747-1754. doi: 10.1007/s00520-019-04966-z. Epub 2019 Jul 13. Support Care Cancer. 2020. PMID: 31302767 Clinical Trial.
-
The effect of cryotherapy on oral mucosa: a study in healthy volunteers.Med Oncol. 2012 Dec;29(5):3587-91. doi: 10.1007/s12032-012-0230-z. Epub 2012 Apr 5. Med Oncol. 2012. PMID: 22476810
-
Systematic review of oral cryotherapy for management of oral mucositis caused by cancer therapy.Support Care Cancer. 2013 Jan;21(1):327-32. doi: 10.1007/s00520-012-1562-0. Epub 2012 Sep 21. Support Care Cancer. 2013. PMID: 22993025
-
Efficacy of oral cryotherapy on oral mucositis prevention in patients with hematological malignancies undergoing hematopoietic stem cell transplantation: a meta-analysis of randomized controlled trials.PLoS One. 2015 May 29;10(5):e0128763. doi: 10.1371/journal.pone.0128763. eCollection 2015. PLoS One. 2015. PMID: 26024220 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical